Cassava Sciences, Inc. (SAVA)
NASDAQ: SAVA · Real-Time Price · USD
1.650
-0.050 (-2.94%)
At close: Mar 28, 2025, 4:00 PM
1.622
-0.028 (-1.70%)
Pre-market: Mar 31, 2025, 4:16 AM EDT

Cassava Sciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Cost of Revenue
6.492.051.6324.813.05
Upgrade
Gross Profit
-6.49-2.05-1.63-24.81-3.05
Upgrade
Selling, General & Admin
71.8116.5311.998.063.74
Upgrade
Research & Development
63.1587.3766.4--
Upgrade
Operating Expenses
134.95103.9178.398.063.74
Upgrade
Operating Income
-141.45-105.96-80.02-32.87-6.79
Upgrade
Interest & Investment Income
8.517.832.780.050.11
Upgrade
Other Non Operating Income (Expenses)
108.590.9110.43-
Upgrade
EBT Excluding Unusual Items
-24.34-97.22-76.25-32.39-6.68
Upgrade
Gain (Loss) on Sale of Assets
----0.35
Upgrade
Pretax Income
-24.34-97.22-76.25-32.39-6.33
Upgrade
Net Income
-24.34-97.22-76.25-32.39-6.33
Upgrade
Net Income to Common
-24.34-97.22-76.25-32.39-6.33
Upgrade
Shares Outstanding (Basic)
4642403926
Upgrade
Shares Outstanding (Diluted)
4742403926
Upgrade
Shares Change (YoY)
11.14%4.30%2.02%50.95%49.93%
Upgrade
EPS (Basic)
-0.53-2.32-1.90-0.82-0.24
Upgrade
EPS (Diluted)
-1.46-2.32-1.90-0.82-0.24
Upgrade
Free Cash Flow
-117.03-82.44-80.23-52.41-5.38
Upgrade
Free Cash Flow Per Share
-2.51-1.97-2.00-1.33-0.21
Upgrade
EBITDA
-140.31-104.43-78.72-32.33-6.77
Upgrade
D&A For EBITDA
1.131.531.30.530.02
Upgrade
EBIT
-141.45-105.96-80.02-32.87-6.79
Upgrade
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q